Monitor for any strategic shifts in the Peripheral Intervention unit under new leadership, but no immediate financial read-through expected.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 4 $209.19entry
- T+1 · 12d ago +2.08%α +6.49% · $213.55
- T+5 · 6d ago +2.55%α +3.46% · $214.52
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
BD appointed Bridget Bagnato as worldwide president of its Peripheral Intervention business unit, effective November 16. Bagnato, a 27-year BD veteran, previously led the Specimen Management unit and will report to the Interventional segment president. The change is a routine leadership rotation with no disclosed financial impact.
Key Facts
- Bridget Bagnato appointed worldwide president of Peripheral Intervention, effective November 16
- Bagnato previously served as worldwide president of BD's Specimen Management business unit
- She has over 27 years at BD in various leadership roles
- She will report to Peter Menziuso, EVP and president of the Interventional segment
- Based in Tempe, Arizona
Financial Impact
No financial figures disclosed; routine leadership change
Risk Factors
- No material risks identified from this appointment
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302928462 |
Track record
17 reports on BDX
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $214.52 Now $216.47 +0.91% settles Nov 18
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $211.88 to $218.03 Now $216.47 +2.17% ▲ +2.90% +0.31% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $211.88 to $218.03 Now $216.47 +2.17% ▲ +2.90% +0.31% vs SPY
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $213.55 to $215.71 Now $216.47 +1.37% ▲ +1.01% −2.28% vs SPY
- Nov 5, 202611d ago Press Release Neutral 3/10 Entry $213.55 to $215.71 Now $216.47 +1.37% ▲ +1.01% −2.28% vs SPY
- Nov 4, 202612d ago Press Release Neutral 2/10 Viewing Entry $209.19 to $214.52 Now $216.47 +3.48% ▲ +2.55% +3.46% vs SPY
- Oct 26, 202621d ago 144 Neutral 2/10 Entry $195.03 to $198.17 Now $216.47 +10.99% ▲ +1.61% +3.60% vs SPY
- Oct 6, 20265w ago Press Release Neutral 2/10 Entry $180.30 to $187.37 Now $216.47 +20.06% ▲ +3.92% +4.06% vs SPY
- Aug 14, 202613w ago Insider Cluster Neutral 2/10 Entry $182.09 to $190.74 Now $216.47 +18.88% ▲ +4.75% +5.94% vs SPY
- Jul 22, 202616w ago 8-K Neutral 2/10 Entry $153.16 to $168.40 Now $216.47 +41.34% ▲ +9.95% +12.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers